Internal Medicine • Vol 63 • No 2
Donor Lymphocyte Infusion for Relapsed Acute Leukemia or Myelodysplastic Syndrome after Hematopoietic Stem Cell Transplantation: A Single-Institute Retrospective Analysis
May 2023 • Masahiro Ogasawara, Rintaro Nozu, Kosuke Miki, Shunnsuke Sugimura, Keisuke Kojima, Daisuke Hidaka, Reiki Ogasawara, Kohei Okada, Junichi Sugita, Naok…
Objective The prognosis of the patients who relapsed after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is poor, and therapeutic options are limited. In the present study, we investigated the efficacy and factors associated with the survival in patients with acute leukemia or myelodysplastic syndrome (MDS) who relapsed following allo-HSCT and were treated with donor lymphocyte infusion (DLI) in real-world practice. Patients Twenty-nine patients with acute myeloid leukemia<sup>21</sup>, acute lymp…